CVS Health expands access to opioid overdose treatment
The company's program to combat the opioid epidemic will thus operate in a total of 30 states by August and make the life-saving drug accessible to patients without an individual prescription.
CVS Health noted that its naloxone program establishes a standing order with a physician in the state, which will permit CVS pharmacists to dispense naloxone to patients without an individual prescription. The company already dispenses naloxone in 23 states. Naloxone is used by first responders to reverse heroin and opioid overdoses.
Expansion of the company's naloxone program will begin with New Mexico in late May. This will be followed by Louisiana in early June; Florida in early July; Colorado, Idaho and Oregon in mid-July; and Washington in early August.
The move to expand access to naloxone builds on CVS Health's commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal.
The company has also launched a community outreach program called Pharmacists Teach, which brings local pharmacists to high school health classes to talk to students about the dangers of drug abuse. ■